Dolby Laboratories Croissance future
Future contrôle des critères 1/6
Dolby Laboratories devrait augmenter ses bénéfices et ses revenus de 8.3% et de 5.6% par an respectivement, tandis que le BPA devrait croître de croître de 7% par an.
Informations clés
8.3%
Taux de croissance des bénéfices
7.0%
Taux de croissance du BPA
| Software croissance des bénéfices | 17.3% |
| Taux de croissance des recettes | 5.6% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 20 Nov 2024 |
Mises à jour récentes de la croissance future
Recent updates
Dolby Laboratories: Picture Improved, But Still A Bit Too Expensive
Nov 22Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns
Oct 28
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Sep 22Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital
Aug 22Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion
Aug 13We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)
Jul 26Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 9/30/2027 | 1,523 | 329 | 509 | 537 | 1 |
| 9/30/2026 | 1,416 | 278 | 458 | 486 | 2 |
| 9/30/2025 | 1,355 | 247 | 427 | 455 | 3 |
| 9/27/2024 | 1,274 | 262 | 297 | 327 | N/A |
| 6/28/2024 | 1,259 | 212 | 265 | 296 | N/A |
| 3/29/2024 | 1,269 | 190 | 365 | 396 | N/A |
| 12/29/2023 | 1,280 | 188 | 290 | 319 | N/A |
| 9/29/2023 | 1,300 | 201 | 337 | 367 | N/A |
| 6/30/2023 | 1,287 | 219 | 301 | 333 | N/A |
| 3/31/2023 | 1,279 | 242 | 348 | 385 | N/A |
| 12/30/2022 | 1,237 | 183 | 303 | 343 | N/A |
| 9/30/2022 | 1,254 | 184 | 259 | 319 | N/A |
| 7/1/2022 | 1,261 | 201 | 316 | 377 | N/A |
| 4/1/2022 | 1,258 | 216 | 314 | 377 | N/A |
| 12/31/2021 | 1,243 | 255 | 332 | 397 | N/A |
| 9/24/2021 | 1,281 | 310 | 393 | 448 | N/A |
| 6/25/2021 | 1,267 | 293 | 398 | 451 | N/A |
| 3/26/2021 | 1,228 | 306 | 359 | 413 | N/A |
| 12/25/2020 | 1,260 | 318 | 334 | 395 | N/A |
| 9/25/2020 | 1,162 | 231 | 275 | 344 | N/A |
| 6/26/2020 | 1,189 | 248 | 287 | 362 | N/A |
| 3/27/2020 | 1,245 | 221 | 234 | 319 | N/A |
| 12/27/2019 | 1,231 | 206 | 195 | 302 | N/A |
| 9/27/2019 | 1,242 | 255 | 214 | 328 | N/A |
| 6/28/2019 | 1,183 | 238 | 194 | 309 | N/A |
| 3/29/2019 | 1,096 | 201 | 253 | 360 | N/A |
| 12/28/2018 | 1,057 | 193 | 307 | 392 | N/A |
| 9/28/2018 | 1,055 | 42 | 267 | 352 | N/A |
| 6/29/2018 | 1,056 | 37 | N/A | 321 | N/A |
| 3/30/2018 | 1,147 | 110 | N/A | 317 | N/A |
| 12/29/2017 | 1,115 | 95 | N/A | 324 | N/A |
| 9/29/2017 | 1,080 | 206 | N/A | 378 | N/A |
| 6/30/2017 | 1,072 | 204 | N/A | 370 | N/A |
| 3/31/2017 | 1,044 | 192 | N/A | 359 | N/A |
| 12/30/2016 | 1,051 | 208 | N/A | 360 | N/A |
| 9/30/2016 | 1,026 | 186 | N/A | 360 | N/A |
| 7/1/2016 | 1,025 | 208 | N/A | 367 | N/A |
| 4/1/2016 | 980 | 180 | N/A | 288 | N/A |
| 1/1/2016 | 977 | 171 | N/A | 373 | N/A |
| 9/25/2015 | 971 | 181 | N/A | 309 | N/A |
| 6/26/2015 | 965 | 181 | N/A | 316 | N/A |
| 3/27/2015 | 956 | 185 | N/A | 360 | N/A |
| 12/26/2014 | 963 | 203 | N/A | 288 | N/A |
| 9/26/2014 | 960 | 206 | N/A | 362 | N/A |
| 6/27/2014 | 950 | 206 | N/A | 339 | N/A |
| 3/28/2014 | 934 | 196 | N/A | 332 | N/A |
| 12/27/2013 | 904 | 182 | N/A | 286 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de DLB ( 8.3% par an) est supérieure au taux d'épargne ( 2.6% ).
Bénéfices vs marché: Les bénéfices de DLB ( 8.3% par an) devraient croître plus lentement que le marché US ( 15.4% par an).
Croissance élevée des bénéfices: Les bénéfices de DLB devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de DLB ( 5.6% par an) devrait croître plus lentement que le marché de US ( 8.9% par an).
Croissance élevée des revenus: Le chiffre d'affaires de DLB ( 5.6% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de DLB devrait être élevé dans 3 ans